Tag #cdmo

At Archimica, we're thrilled to explore the transformative potential of Sucrose Octasulfate Potassium Salt (KSOS) in revolutionizing pharmaceutical applications. From enhancing the stability of high-value treatments to improving liposome-based drug delivery systems, ...
Read More
Archimica is excited to be a part of DCAT Week 2025, where we'll be showcasing our latest breakthroughs and innovations in pharmaceutical manufacturing. Let's connect and discuss how we can ...
Read More
We are happy to announce that Archimica is now CEP (Certification of Suitability) certified by the EDQM (European Directorate for the Quality of Medicines & HealthCare) for our API product, ...
Read More